Evaluation of the activity of bispirazoles against recombinant Trypanosoma cruzi strains expressing ß-galactosidase
Background: Nifurtimox and benznidazole are the only drugs currently approved to treat Chagas disease, caused Trypanosoma cruzi. However, they display unsatisfactory efficacy and induce undesirable side effects. Therefore, identifying new compounds with specific activity against T. cruzi is of great...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | article |
| Publicado em: |
2023
|
| Assuntos: | |
| Acesso em linha: | https://repositorio.puce.edu.ec/handle/123456789/43351 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Adicionar Tag